CD8+ T cells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer
Journal of Clinical Investigation · 02.02.2026 · 136 (3)
DOI: 10.1172/jci188458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 09.12.2025. Verfasst von Fabiana Napolitano und 30 weiteren Autor:innen. Beteiligte Einrichtung: UT Southwestern Simmons Comprehensive Cancer Center, Department of Internal Medicine, University of Texas Southwestern (UTSW) Medical Center, Dallas,…. Hauptthemen laut MEDLINE: Breast Neoplasms, Tumor Microenvironment, CD8-Positive T-Lymphocytes, Lymphocytes, Tumor-Infiltrating. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
The role of the tumor immune microenvironment (TIME) in modulating responses to antiestrogen therapy in hormone receptor–positive (HR + ) breast cancers remains unclear. We analyzed pre- and on-treatment biopsies from patients with HR + breast cancer treated with letrozole to induce estrogen deprivation (ED). Stromal tumor–infiltrating lymphocytes, assessed by H&E staining, and immune-related gene sets, including IFN-γ signaling genes, measured by RNA-Seq, were increased in ED-resistant tumors. Cyclic immunofluorescence and spatial transcriptomics revealed an abundance of CD8 + T cells and enhanced antigen processing and immune gene signatures in ED-resistant tumors. In this group, the expression of CXCL9 , CXCL10 , and CXCL11 — chemokine genes involved in CD8 + T cell recruitment — and the CXCR3 receptor were upregulated both before and after letrozole treatment. CXCL11 levels were higher in conditioned media from HR + breast cancer cells cocultured with CD8 + T cells. Both recombinant CXCL11 and coculture with CD8 + T cells promoted MCF7 and T47D cell growth in estrogen-free conditions. Finally, deletion combined with silencing of the CXCL11 receptors CXCR3 and CXCR7 in MCF7 cells impaired proliferation in response to exogenous CXCL11 and to coculture with CD8 + T cells in estrogen-free conditions. These findings suggest that CD8 + T cell–associated CXCL11 in the TIME modulated the response of HR + breast cancer cells to estrogen suppression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UT Southwestern Simmons Comprehensive Cancer Center, Department of Internal Medicine, University of Texas Southwestern (UTSW) Medical Center, Dallas, Texas, USA.
- Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
- Division of Pediatric Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.
- Departments of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center (VUMC), Nashville, Tennessee, USA.
- Department of Medical Oncology.
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- National Cancer Institute
- U.S. Department of Defense
- Cancer Prevention and Research Institute of Texas
- Susan G. Komen Breast Cancer Foundation
- Breast Cancer Research Foundation
Zitieren
APA
Napolitano, F., Wang, Y., Sudhan, D. R., Gonzalez-Ericsson, P. I., Formisano, L., Unni, N., Shakeel, S., Zhu, J. Z., Ahuja, K., Guo, L., Chica-Parrado, M. R., Matsunaga, Y., Luna, P., Lin, C. A., Uemoto, Y., Lee, K. M., Ma, H., Evans, N. J., Servetto, A., …, & Arteaga, C. L. (2026). CD8+ T cells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer. Journal of Clinical Investigation, 136(3). https://doi.org/10.1172/jci188458
Vancouver
Napolitano F, Wang Y, Sudhan DR, Gonzalez-Ericsson PI, Formisano L, Unni N, et al. CD8+ T cells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer. Journal of Clinical Investigation. 2026;136(3). doi:10.1172/jci188458
BibTeX
@article{Napolitano2026,
author = {Napolitano, Fabiana and Wang, Yunguan and Sudhan, Dhivya R and Gonzalez-Ericsson, Paula I and Formisano, Luigi and Unni, Nisha and Shakeel, Shahbano and Zhu, James Z and Ahuja, Khushi and Guo, Lei and Chica-Parrado, María Rosario and Matsunaga, Yuki and Luna, Pamela and Lin, Chang-Ching A and Uemoto, Yasuaki and Lee, Kyung-Min and Ma, Hongli and Evans, Nathaniel J and Servetto, Alberto and Mendiratta, Saurabh and Barnes, Spencer D and Bianco, Roberto and Fang, Yisheng V and Xu, Lin and Lee, Jeon and Wang, Tao and Balko, Justin M and Mills, Gordon B and Labrie, Marilyne and Hanker, Ariella B and Arteaga, Carlos L},
title = {CD8+ T cells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {3},
doi = {10.1172/jci188458}
}
EUVIMED